Biotechnology Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy – Ocugen (NASDAQ:OCGN) Read more
Biotechnology Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results Read more
Eurozone German Lawmakers Eager To See Phase 2 Of Cannabis Legalization, Weed Giant Curaleaf Considers Listing In Frankfurt – Curaleaf Holdings (OTC:CURLF) Read more
Biotechnology New Hope for Aggressive Lung Cancer: AstraZeneca’s Imfinzi Shows Promising Results in Phase 3 Trial – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Stoke Therapeutics Stock Rockets On Phase 1/2a Data: Here’s Why – Stoke Therapeutics (NASDAQ:STOK) Read more
Biotechnology Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal Conjugate Vaccine – Merck & Co (NYSE:MRK) Read more
Biotechnology IGC Pharma Advances In Alzheimer’s Research From Pre-clinical Studies To Phase Two Trials With Its Novel Therapy Candidate IGC-AD1 – IGC Pharma (AMEX:IGC) Read more